10x Genomics SMA 200
Cos'è SMA 200 di 10x Genomics?
SMA 200 di 10x Genomics, Inc. è $27 -23.05%
Qual è la definizione di SMA 200?
SMA 200 è un prezzo medio delle azioni degli ultimi 200 giorni calcolato come media non ponderata dei precedenti 200 prezzi di chiusura delle scorte.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 di aziende nel Health Care settore su NASDAQ rispetto a 10x Genomics
Cosa fa 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Aziende con sma 200 simili a 10x Genomics
- Box Inc ha SMA 200 di $27 +17.83%
- Meituan Dianping ha SMA 200 di $27 +11.85%
- Pennant International plc ha SMA 200 di GBX27 -1.41%
- Meituan Dianping ha SMA 200 di $27 +11.84%
- Equinor ASA ha SMA 200 di $27 -11.01%
- Guangdong Investment ha SMA 200 di $27 +4.05%
- 10x Genomics ha SMA 200 di $27 -23.05%
- Vornado Realty Trust ha SMA 200 di $27 +20.29%
- Digi International ha SMA 200 di $27 -4.87%
- K G Denim ha SMA 200 di ₨27 -3.93%
- HT Media ha SMA 200 di ₨27 -12.46%
- Japan Tobacco ha SMA 200 di $27 +4.73%
- Franklin Services ha SMA 200 di $27 +15.60%